{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:36Z","timestamp":1777870416635,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40620-015-0202-4","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T04:35:45Z","timestamp":1431923745000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study"],"prefix":"10.1093","volume":"29","author":[{"given":"Maurizio","family":"Gallieni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Meneghel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Formica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pizzarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Segoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Quintaliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Di Giulio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moreno","family":"Malaguti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosimo","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamberto","family":"Oldrizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Pacilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Dal Canton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Minutolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"202_CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.arrt.2004.01.010","volume":"11","author":"FE Yeo","year":"2004","unstructured":"Yeo FE, Villines TC, Bucci JR, Taylor AJ, Abbott KC (2004) Cardiovascular risk at stage 4 and 5 nephropathy. Adv Chronic Kidney Dis 11:116\u2013133","journal-title":"Adv Chronic Kidney Dis"},{"issue":"Suppl 12","key":"202_CR2","first-page":"S16","volume":"9","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(Suppl 12):S16\u2013S23","journal-title":"J Am Soc Nephrol"},{"key":"202_CR3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","volume":"20","author":"R Vanholder","year":"2005","unstructured":"Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N (2005) European Uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20:1048\u20131056","journal-title":"Nephrol Dial Transplant"},{"key":"202_CR4","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/ndt\/gft338","volume":"28","author":"R Minutolo","year":"2013","unstructured":"Minutolo R, Locatelli F, Gallieni M, Bonofiglio R, Fuiano G, Oldrizzi L, Conte G, De Nicola L, Mangione F, Esposito P, Dal Canton A (2013) REport of COmorbidities in non-Dialysis Renal Disease Population in Italy (RECORD-IT) Study Group. Anemia management in non-dialysis chronic kidney disease (CKD) patients: a multicenter prospective study in renal clinics. Nephrol Dial Transplant 28:3035\u20133045","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4","key":"202_CR5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","volume":"53","author":"R Bhuriya","year":"2009","unstructured":"Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL (2009) Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 53(Suppl 4):S3\u2013S10","journal-title":"Am J Kidney Dis"},{"key":"202_CR6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119\u20131127","journal-title":"JAMA"},{"key":"202_CR7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520\u2013528","journal-title":"J Am Soc Nephrol"},{"key":"202_CR8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","volume":"1","author":"S Schwarz","year":"2006","unstructured":"Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP (2006) Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1:825\u2013831","journal-title":"Clin J Am Soc Nephrol"},{"key":"202_CR9","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","author":"N Voormolen","year":"2007","unstructured":"Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW (2007) PREPARE study group. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transpl 22:2909\u20132916","journal-title":"Nephrol Dial Transpl"},{"key":"202_CR10","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2215\/CJN.00810110","volume":"5","author":"H Eddington","year":"2010","unstructured":"Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, Hegarty J, New J, O\u2019Donoghue DJ, Middleton RJ, Kalra PA (2010) Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 5:2251\u20132257","journal-title":"Clin J Am Soc Nephrol"},{"key":"202_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2215\/CJN.07810910","volume":"6","author":"A Bellasi","year":"2011","unstructured":"Bellasi A, Mandreoli M, Baldrati L, Corradini M, Di Nicol\u00f2 P, Malmusi G, Santoro A (2011) Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol 6:883\u2013891","journal-title":"Clin J Am Soc Nephrol"},{"key":"202_CR12","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2215\/CJN.01180211","volume":"6","author":"L Nicola De","year":"2011","unstructured":"De Nicola L, Chiodini P, Zoccali C, Borrelli S, Cianciaruso B, Di Iorio B, Santoro D, Giancaspro V, Abaterusso C, Gallo C, Conte G, Minutolo R, SIN-TABLE CKD Study Group (2011) Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin J Am Soc Nephrol 6:2421\u20132428","journal-title":"Clin J Am Soc Nephrol"},{"key":"202_CR13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","volume":"22","author":"Zoccali C, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Mallamaci F, Remuzzi G; REIN Study Group","year":"2011","unstructured":"Zoccali C, Ruggenenti P, Perna A, Leonardis D, Tripepi R, Tripepi G, Mallamaci F, Remuzzi G; REIN Study Group (2011) Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 22:1923\u20131930","journal-title":"J Am Soc Nephrol"},{"key":"202_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338","journal-title":"Kidney Int"},{"key":"202_CR15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","volume":"22","author":"L Craver","year":"2007","unstructured":"Craver L, Marco MP, Mart\u00ednez I, Rue M, Borr\u00e0s M, Mart\u00edn ML, Sarr\u00f3 F, Valdivielso JM, Fern\u00e1ndez E (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2014achievement of K\/DOQI target ranges. Nephrol Dial Transplant 22:1171\u20131176","journal-title":"Nephrol Dial Transplant"},{"key":"202_CR16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","volume":"20","author":"O Moranne","year":"2009","unstructured":"Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M\u2019rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B, NephroTest Study Group (2009) Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 20:164\u2013171","journal-title":"J Am Soc Nephrol"},{"key":"202_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jch.12095","volume":"15","author":"N Desai","year":"2013","unstructured":"Desai N, Madhavankutty Saraswathy V, Hunter K, McFadden C (2013) Prevalence of true therapeutic inertia in blood pressure control in an academic chronic kidney disease clinic. J Clin Hypertens (Greenwich) 15:375\u2013379","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"202_CR18","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/01.hjh.0000239303.93872.31","volume":"24","author":"R Minutolo","year":"2006","unstructured":"Minutolo R, Sasso FC, Chiodini P, Cianciaruso B, Carbonara O, Zamboli P, Tirino G, Pota A, Torella R, Conte G, De Nicola L (2006) Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings. J Hypertens 24:1655\u20131661","journal-title":"J Hypertens"},{"key":"202_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-12-53","volume":"12","author":"A Mart\u00ednez-Castelao","year":"2011","unstructured":"Mart\u00ednez-Castelao A, G\u00f3rriz JL, Portol\u00e9s JM, De Alvaro F, Cases A, Lu\u00f1o J, Navarro-Gonz\u00e1lez JF, Montes R, De la Cruz-Troca JJ, Natarajan A, Batlle D (2011) Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC Nephrol 12:53","journal-title":"BMC Nephrol"},{"key":"202_CR20","first-page":"152","volume":"22","author":"M Nordio","year":"2005","unstructured":"Nordio M, Postorino M, Casino F, Mancini E, Salomone M, Conte F (2005) Standardization criteria to ensure the uniformity of data collection by the Italian Registry of Dialysis and Transplantation. Giorn It Nefrol 22:152\u2013158","journal-title":"Giorn It Nefrol"},{"issue":"4 Suppl 3","key":"202_CR21","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1\u2013S201","journal-title":"Am J Kidney Dis"},{"key":"202_CR22","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1\u2013S130","journal-title":"Kidney Int Suppl"},{"key":"202_CR23","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jacc.2012.12.061","volume":"61","author":"L Nicola De","year":"2013","unstructured":"De Nicola L, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Bellizzi V, Nappi F, Conte G, Minutolo R (2013) Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients. J Am Coll Cardiol 61:2461\u20132467","journal-title":"J Am Coll Cardiol"},{"key":"202_CR24","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1053\/j.ajkd.2007.12.018","volume":"51","author":"JA Vassalotti","year":"2008","unstructured":"Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, Calvo MS, Whaley-Connell AT, McCullough PA, Norris KC (2008) Kidney Early Evaluation Program Investigators. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999\u20132004. Am J Kidney Dis 51:S56\u2013S68","journal-title":"Am J Kidney Dis"},{"key":"202_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","volume":"168","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 168:397\u2013403","journal-title":"Arch Intern Med"},{"key":"202_CR26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ki.2008.35","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Kalantar-Zadeh K (2008) Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 73:1355\u20131363","journal-title":"Kidney Int"},{"key":"202_CR27","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73:1296\u20131302","journal-title":"Kidney Int"},{"key":"202_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","volume":"26","author":"JB Cannata-And\u00eda","year":"2013","unstructured":"Cannata-And\u00eda JB, Rodriguez Garc\u00eda M, G\u00f3mez Alonso C (2013) Osteoporosis and adynamic bone in chronic kidney disease. J Nephrol 26:73\u201380","journal-title":"J Nephrol"},{"key":"202_CR29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1309\/AJCPLGCZR7IPVHA7","volume":"134","author":"SL La\u2019ulu","year":"2010","unstructured":"La\u2019ulu SL, Roberts WL (2010) Performance characteristics of six intact parathyroid hormone assays. Am J Clin Pathol 134:930\u2013938","journal-title":"Am J Clin Pathol"}],"updated-by":[{"DOI":"10.1007\/s40620-015-0215-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000}}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-015-0202-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-015-0202-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:34Z","timestamp":1777564654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/1\/71\/8371424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s40620-015-0202-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}